SEK
EUR
USD
NEUROSCIENCE CAMPAIGN 20% DISCOUNT ON PRIMARY ANTIBODIES!
Cart
0
Products
Antibody Validation
Applications
Protocols
Knowledge Hub
Customer Support
About Us
Cart
0
Search
Show all Products
MolBoolean
PrEST Control Antigens
Primary Antibodies
PrecisA Monoclonals
Triple A Polyclonals
Antibody Validation
Enhanced Validation
Applications
Immunohistochemistry
Immunocytochemistry
Western Blot
Atlas Antibodies to Showcase Innovation at Society for Neuroscience Annual Meeting 2024 in Chicago
Atlas Antibodies Presents Pan-Cancer Markers and New Product MolBoolean at EACR 2024
Atlas Antibodies Unveils Revolutionary Molecular Tool, MolBoolean™
Atlas Antibodies is going green!
Ingela Hofverberg appointed as CEO of Atlas Antibodies BU
The Human Protein Atlas (HPA) selected as a Global Core Biodata Resource
Free webinar: „Importance of reliable antibodies in tumor pathology: focus on gynecological pathology”
Welcome and meet us at 2023 BNA Festival
Let’s meet at EACR 2023 in Turin on 12-15 June
Webinar: “Exploring neural lineages with brain organoids and their implications for understanding health and disease”
Atlas Antibodies acquires HistoCyte Laboratories Ltd.
Atlas Antibodies acquires evitria
Atlas Antibodies is awarded ISO 9001:2015 Certification for Quality Management System
Atlas Antibodies’ products enriches Biomol’s offer
Atlas Antibodies nearly tripled its size during 2021
Winner of the Atlas Antibodies’ travel grant of 500 euros to attend the FENS Forum 2022 in Paris
Great time with neuroscientists at FENS 2022
Atlas Antibodies has new Chair of the Board Åsa Riisberg
Dr. Stefan Schmidt new CEO of evitria
Gavin Wood and Christian Eberle join Atlas Antibodies’ Board of Directors
